Don’t miss the latest developments in business and finance.

Sharon Bio-Medicine standalone net profit rises 97.54% in the September 2022 quarter

Image
Capital Market
Last Updated : Nov 12 2022 | 9:16 AM IST

Sales rise 19.38% to Rs 53.95 crore

Net profit of Sharon Bio-Medicine rose 97.54% to Rs 8.85 crore in the quarter ended September 2022 as against Rs 4.48 crore during the previous quarter ended September 2021. Sales rose 19.38% to Rs 53.95 crore in the quarter ended September 2022 as against Rs 45.19 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales53.9545.19 19 OPM %19.8515.18 -PBDT11.547.30 58 PBT8.854.48 98 NP8.854.48 98

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Nov 12 2022 | 8:10 AM IST

Next Story